Nivolumab Safely Added to ChemoRT for Advanced Head and Neck Cancer
MedPage Today,
Immunotherapy with nivolumab can be safely added to radiation therapy and chemotherapy for patients with newly diagnosed…
Nivolumab made available for head and neck cancers on the Cancer Drugs Fund. ecancer
ecancer,
The immunotherapy nivolumab has today been made available on the Cancer Drugs Fund (CDF) for patients with head and neck cancer…
Nivolumab Maintained QOL in Advanced Squamous Cell Head and Neck Cancer
UBM Medica,
Patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with the checkpoint inhibitor…
Nivolumab Improved Patient-Reported QOL Compared With Investigator's Choice: CheckMate 141
AJMC,
The study, published in Lancet Oncology, has found that nivolumab reduced the rate of clinically meaningful deterioration…